Companies · Other Health Care
PITTSFORD · Other Health Care
Diligence memoA one-page analyst read on NY Medicinal Research & Caring, LLC — recommendation, valuation, rhythm, risks.→NY Medicinal Research & Caring, LLC looks fair against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
NY Medicinal Research & Caring, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
NY Medicinal Research & Caring, LLC is one of 5377 Other Health Care companies tracked from PITTSFORD. By capital raised it ranks in the upper tier (ahead of 73% of sector peers), and in the upper tier by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.
Round size and date are reported; the stage label is inferred from round size (latest is Series A — a $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 73% of sector peers (real $). Modeled value above 86% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #40 of 157.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| HemoSonics, LLC | Series A | $24.9M | $302.7M | 2.50× |
| Airxpanders Inc | Series A | $60.0M | $300.5M | 2.48× |
| Mercator Medsystems Inc | Series A | $20.5M | $289.2M | 2.39× |
| Simple Contacts Inc. | Series A | $24.1M | $285.5M | 2.36× |
| AVG Holdings, Inc. | Series A | $14.0M | $282.5M | 2.33× |
| Avia Holdings, Llc | Series A | $27.9M | $272.7M | 2.25× |
| Traditions at Rivertown Park, LLC | Series A | $13.5M | $272.4M | 2.25× |
| Access Integrated Healthcare, LLC | Series A | $13.2M | $265.8M | 2.20× |
| Gauss Surgical, Inc. | Series A | $20.5M | $254.2M | 2.10× |
| 4WEB, Inc. | Series A | $12.5M | $252.2M | 2.08× |
| Iantech, Inc. | Series A | $12.2M | $246.7M | 2.04× |
| AbsoluteCARE, Inc. | Series A | $25.7M | $242.6M | 2.00× |
| NY Medicinal Research & Caring, LLC this company | Series A | $8.8M | $178.0M | 1.47× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series A | $8.8M | 2016-11-15 | $40.1M | $178.0M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Kevin P. Murphy | — | 3 other | 2016-11 |
| Frank P Catanzano | — | — | 2016-11 |
| Michael P Linehan | — | — | 2016-11 |
NY Medicinal Research & Caring, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Gramercy Extremity Orthopedics, LLC | Other Health Care | Series A | $8.8M | $178.3M | same sector · same stage |
| Docusys Inc | Other Health Care | Series A | $8.8M | $178.4M | same sector · same stage |
| Tree Street Holdings | Other Health Care | Series A | $8.8M | $177.6M | same sector · same stage |
| Previser Corp | Other Health Care | Series A | $8.8M | $168.5M | same sector · same stage |
| Fresenius Vascular Care Pensacola, LLC | Other Health Care | Series A | $8.9M | $178.7M | same sector · same stage |
| Red Fox Holding Corp | Other Health Care | Series A | $8.9M | $179.2M | same sector · same stage |
| ExploraMed V, L.L.C. | Other Health Care | Series A | $8.8M | $176.7M | same sector · same stage |
| Verge Solutions, LLC | Other Health Care | Series A | $8.7M | $176.5M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| CaredFor, Inc. | Other Health Care | Pre-Seed | $22.7M | 83% |
| Botany Scientifics LLC | Other Health Care | Pre-Seed | $1.4M | 83% |
| Research Imaging Company, LLC | Other Health Care | Series C | $679.4M | 83% |
| Northern Westchester Facility Project LLC | Other Health Care | Pre-Seed | $1.6M | 82% |
| Georgia Medicinal Partners, LLC | Other Health Care | Pre-Seed | $2.2M | 82% |
| Nymbl Science, Inc. | Other Health Care | Series A | $3.1M | 82% |
| MediCall Inc. | Other Health Care | Pre-Seed | $7.3M | 81% |
| GenomOncology, LLC | Other Health Care | Seed | $79.3M | 81% |
See where NY Medicinal Research & Caring, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at NY Medicinal Research & Caring, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.